Retrospective Analysis Of Progression Free Survival And Overall Survival In A National Cohort Of Patients With Metastatic Renal Cell Carcinoma Treated In Denmark From 2006-2010. DARENCA Study 2.
Clinical trial NCT01339962 · COMPLETED
Trial details
- NCT number
- NCT01339962
- Sponsor
- Pfizer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2011-04-01
- Primary completion
- 2012-04-01
- Enrollment
- 1073
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.